TP53 and cancer: We computed the fraction of samples with at least one gene altered in each pathway, and found that p53, RTK-RAS, and Wnt were the most frequently mutated pathways, while MYC, cell cycle, and Hippo pathways had the lowest mutation ratio in nearly all cancers (Figure 1C).